Article

Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver disease

2026-02-20

Abstract excerpt

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent condition that progresses from simple steatosis to advanced fibrosis, significantly affecting liver function and systemic health. Despite its widespread impact, therapeutic options are limited, highlighting the urgent need for comprehensive exploration to identify potential therapeutic targets. In this study, we created an analysis pip...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f580d47c-dd56-5e31-b621-a4ddfd2cdc50
DOI: 10.64898/2026.02.19.706502

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver diseaseDOI 10.64898/2026.02.19.706502Read

Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome AnalysisSemantic proximity Read

Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progressionSemantic proximity Read

Single cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitisSemantic proximity Read

Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progressionSemantic proximity Read

Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learningSemantic proximity Read

A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverSemantic proximity Read

Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analysesSemantic proximity Read

UK Biobank-Based Genetic and Proteomic Network Insights into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis.Semantic proximity Read

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read

Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Global molecular landscape of early MASLD progression in obesitySemantic proximity Read

Sex-specific lipid-mediated mechanisms drive MASLD progression revealed by paired liver–blood multi-omicsSemantic proximity Read